Related Experiment Video
Updated: Jun 21, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
1Division of Haematology, Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
Abstract:
As our understanding of the molecular mechanisms governing natural killer (NK) cell activity increases, their potential in cancer immunotherapy is growing increasingly prominent. This review analyses the currently available preclinical and clinical data regarding NK cell-based immunotherapeutic approaches in cancer starting from a historical background and an overview of molecular mechanisms taking part in NK cell responses. The status of NK cells in cancer patients, currently investigated clinical applications such as in vivo modulation of NK cell activity, ex vivo purification/expansion and adoptive transfer as well as future possibilities such as genetic modifications are discussed in detail.
Insights
Natural killer (NK) cell immunotherapy shows promise for cancer treatment. This review covers NK cell mechanisms, their role in cancer, and current/future therapeutic strategies for enhanced cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Natural killer (NK) cells are crucial immune cells with inherent cytotoxic activity against tumor cells.
- Understanding NK cell molecular mechanisms is key to developing effective cancer immunotherapies.
- NK cell dysfunction is observed in cancer patients, impacting anti-tumor immunity.
Purpose of the Study:
- To review preclinical and clinical data on NK cell-based cancer immunotherapy.
- To provide a historical overview and discuss molecular mechanisms of NK cell responses.
- To explore current and future therapeutic applications of NK cells in oncology.
Main Methods:
- Literature review of preclinical and clinical studies on NK cell immunotherapy.
- Analysis of molecular mechanisms regulating NK cell activity.
- Discussion of clinical applications including in vivo modulation, ex vivo expansion, and adoptive transfer.
Main Results:
- NK cell-based therapies are a rapidly advancing field in cancer treatment.
- Various strategies are being investigated to enhance NK cell activity against tumors.
- Genetic modification offers future potential for optimizing NK cell-based cancer immunotherapy.
Conclusions:
- NK cell immunotherapy holds significant potential for treating various cancers.
- Further research into NK cell biology and therapeutic applications is warranted.
- Optimizing NK cell function is critical for successful cancer immunotherapy outcomes.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

